Page 31 - Novartis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dorsey & Whitney Trust CO LLC Grows Stock Holdings in Novartis AG (NYSE:NVS)

Dorsey & Whitney Trust CO LLC raised its position in shares of Novartis AG (NYSE:NVS – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,319 shares of the company’s stock after buying an additional 254 shares during the quarter. Dorsey […]

Goldman sachs groupDorsey whitney trustRepublic capitalSteward partners investment advisoryNovartis company profileTd asset management incPine valley investments ltd liability coWhitney trustFree reportManagement incPartners investment advisoryGet free reportNovartis daily

Dorsey & Whitney Trust CO LLC Increases Stock Holdings in Novartis AG (NYSE:NVS)

Dorsey & Whitney Trust CO LLC raised its stake in Novartis AG (NYSE:NVS – Free Report) by 1.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 14,319 shares of the company’s stock after acquiring an additional 254 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in Novartis were worth $1,446,000 as […]

Means investmentDorsey whitney trustGoldman sachs groupMurphy middleton hinkle parker incPinnacle bancorp incChesley taft associatesWhitney trustFree reportMiddleton hinkleInvestment advisorsGet free reportVisit holdingschannelNovartis daily

Health: Novartis leukemia drug more effective than older treatments in trial

Health: Novartis leukemia drug more effective than older treatments in trial
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United statesBristol myers squibb sprycelNovarti tasignaAmerican society of clinical oncologyAmerican societyClinical oncologyBristol myers squibb

Novartis (NYSE:NVS) Coverage Initiated at The Goldman Sachs Group

Investment analysts at The Goldman Sachs Group began coverage on shares of Novartis (NYSE:NVS – Get Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $120.00 price target on the stock. The Goldman Sachs Group’s price objective would suggest a potential upside of 16.36% from the […]

Magnetar financialEnvestnet asset management incGrantham mayo van otterloo coMondrian investment partnersMorningstar investment servicesGoldman sachs groupGet free reportMayo van otterlooAsset managementInvestment partnersInvestment servicesNovartis daily

Iraqi Foreign Minister: Switzerland to reopen embassy in Baghdad within months

In an exclusive interview with Swissinfo, the Iraqi foreign minister announced that Switzerland will reopen its embassy in Baghdad within months.

United statesIsrael generalSwitzerland generalSwiss confederationRepublic of iraqVirginie manginFouad husseinElisabeth baume schneiderFuad husseinOffice of cultureWorld economic forum in davosJournalism trust initiativeForeign affairs of the republic iraqInternational organization for migrationAfrica department maya tissafiOffice for culture